Strategic Partnerships Five Star Diagnostics has existing partnerships with major health plans for mobile retinal exams, indicating a valuation and demand for payer-aligned services. Sales opportunities exist in expanding contractual relationships with additional payors and managed care organizations to broaden coverage and drive adoption of mobile diagnostic capabilities.

Performance Impact Payors report incremental improvements in STAR ratings for Diabetic Retinopathy Exams when working with Five Star Diagnostics. This can be highlighted to prospective clients as a measurable quality and value proposition to support payer initiatives, value-based care programs, and potential reimbursement advantages.

Growth Potential Revenue is currently in the $1M-$10M range with a small team (2-10 employees), suggesting room for scale. Sales opportunities include targeted outreach to larger healthcare networks and specialty labs where centralized or mobile retinal screening can be integrated into existing ophthalmology or primary care pathways.

Tech Enablement The tech stack leverages widely adopted tools (WordPress, Google Workspace, common web tech). There is potential to upsell or propose enhancements around patient engagement portals, secure data exchange with payors, and integration with electronic health records to streamline referrals and reporting.

Competitive Positioning Compare drivers with similar reference labs and diagnostic services that serve payors and hospitals. Position Five Star Diagnostics as a differentiated mobile retinal solution with payer-aligned outcomes, suggesting opportunities to target mid-market hospital systems and independent labs seeking to augment diabetic retinopathy screening programs.